As for ERK, similar effect of rapamycin, another specific mTORC1 inhibitor, increasing ERK activity through S6K/PI3K/Ras-dependent feedback loop, was revealed in both normal and cancer cells [55]. The gene discussed is MAPK1; the disease is cancer.